|
|
Article: Pharma/biotech mergers and acquisitions in 2008.
- Article from:
- Pharma Marketletter
- Article date:
- January 12, 2009
CopyrightCOPYRIGHT 2009 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Company Partner Deal value ($) Completed
Abbott Laboratories Ibis Biosciences $210.0 million Jan 2009 (e) Abraxis BioScience Shimoda $15.0 million Apr 2008 Access Pharmaceuticals MacroChem Undisclosed 3Q 2008 (e) AVI BioPharma Ercole Biotech $9.0 million Mar 2008 Aida Pharma Jiangsu Institute of Microbiology undisclosed Mar 2008 American Oriential Bioengineering China Aoxing (38% stake) $18.0 million TBC Amneal Pharmaceuticals Interpharm Undisclosed TBC Antisoma Xanthus Pharmaceuticals $52.2 million TBC Apotheka MACH4 (25% stake) Undisclosed TBC Aspen Shelys Africa (60% stake) Undisclosed TBC Affymetrix Panomics $73.0 million TBC AstraZeneca Merck & Co (rights to ...
Related newspaper, magazine, and journal articles:
|
|
Article: DAIICHI SANKYO Sets up Affiliate in Turkey.
PR Newswire Europe;
May 13, 2008 ;
700+ words
... ... Important Step in Global Expansion DAIICHI SANKYO, one of the world's leading research ... Turkey. The company, to be called DAIICHI SANKYO IlaAs. Tikaret Ltd., will be headquartered ... presence," said Reinhard Bauer, CEO of DAIICHI SANKYO EUROPE. "With this decision, we ...
|
|